Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.

Caruso TeresitaSalani FrancescaCatanese SilviaFederico PratesiMercinelli ChiaraMotta GiuseppeGenovesi VirginiaBonato AdeleSara GalimbertiMasi GianlucaMigliorini Paola

Published in: International journal of clinical oncology (2023)

The data indicate that in cancer patients mRNA vaccine induces high avidity anti-RBD antibodies and neutralizing antibodies that increase after the third dose. The process of induction and selection of high-affinity antibodies is apparently unaffected by the treatment with anti-PD-1 or anti-PD-L1 antibodies.

Keyphrases

sars cov
papillary thyroid
machine learning
young adults
respiratory syndrome coronavirus
binding protein
coronavirus disease
combination therapy
zika virus
artificial intelligence
childhood cancer